Enservco (AMEX:ENSV) reported $4.08 million in sales this quarter. This is a 70.71 percent increase over sales of $2.39 million the same period last year.
HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $20
HC Wainwright & Co. analyst Andrew Fein maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and raises the price target from $15 to $20.